Clinical Trials Logo

Clinical Trial Summary

Drug-drug interaction study of midazolam and AT-527 (R07496998)

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT04865445
Study type Interventional
Source Atea Pharmaceuticals, Inc.
Contact Atea Study Clinical T Administrator
Phone +618884811607
Email [email protected]
Status Recruiting
Phase Phase 1
Start date April 22, 2021
Completion date May 2021

See also
  Status Clinical Trial Phase
Completed NCT03270878 - Glasdegib Absolute Bioavailability Study Phase 1
Completed NCT03777488 - Pharmacokinetics of Tranexamic Acid After Oral, Intramuscular or Intravenous Administration: a Prospective, Randomised, Cross-over Trial in Healthy Volunteers. Phase 1
Completed NCT03086278 - A Study of AST-008 in Healthy Subjects Phase 1
Recruiting NCT04711187 - Study of AT-527 in Healthy Subjects (R07496998) Phase 1
Completed NCT03945344 - Effect of Charcoal on Gastrointestinal Absorption of Tiotropium Phase 1
Completed NCT01609218 - A Study of LY2140023 in Healthy Participants Phase 1
Recruiting NCT04242953 - Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects Phase 1
Completed NCT02393950 - Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers Phase 1
Completed NCT00866385 - AZD8566 Food Effect/Microtracer Study Phase 1
Recruiting NCT04784000 - Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527 Phase 1
Completed NCT02503085 - Ibuprofen Suspension Bioequivalence Study Phase 1
Completed NCT02256423 - A Study Comparing Three Formulations of Ibuprofen in Healthy Subjects Phase 1
Completed NCT01425450 - Safety Study of Four Doses of the Study Drug, HF1020 in Healthy Volunteers Phase 1
Completed NCT03031535 - Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers Phase 1
Completed NCT02452450 - Ibuprofen and Paracetamol Pharmacokinetic Study Phase 1
Completed NCT04836572 - An Open-label, Non Significant Risk, Adhesive Wear Validation Study for the On Body Drug Delivery Device Component of the SQIN-01 Furosemide Infusor (Infusor Device) N/A
Recruiting NCT01996605 - Efficacy of Spinal Oxytocin in Healthy Volunteers Phase 2
Recruiting NCT04877769 - Bronchopulmonary PK of AT-527 (R07496998) Phase 1
Not yet recruiting NCT04849299 - Effect of Cyclosporine on the Pharmacokinetics (PK) of AT-527 (R07496998) Phase 1
Completed NCT01564199 - Phase I Pharmacokinetic Study (SALBLOCK) Phase 1